The effect of endothelial progenitor cells on the development of collateral formation in patients with coronary artery disease

Internal Medicine

Volumn 47, Issue 3, 2008, Pages 127-134

  Matsuo, Yoshiki ^a   Imanishi, Toshio ^a   Hayashi, Yasushi ^a   Tomobuchi, Yoshiaki ^a   Kubo, Takashi ^a   Hano, Takuzo ^a   Akasaka, Takashi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Collateral; Coronary artery disease; Endothelial progenitor cell; Growth factor

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOGENIC FACTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BASIC FIBROBLAST GROWTH FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA GALACTOSIDASE; CALCIUM ANTAGONIST; CHEMOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUORESCEIN ISOTHIOCYANATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NICORANDIL; NITRATE; SCATTER FACTOR; ULEX EUROPAEUS AGGLUTININ; VASCULOTROPIN;

ACETYLATION; ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOGENESIS; ARTICLE; BLOOD SAMPLING; CELL AGING; CELL COUNT; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CLINICAL ARTICLE; COLLATERAL CIRCULATION; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CULTURE MEDIUM; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MALE; PHENOTYPE; PROTEIN SECRETION; STEM CELL; CORONARY ARTERY BLOOD FLOW; CYTOLOGY; HEART INFARCTION; MIDDLE AGED; PATHOPHYSIOLOGY; RADIOGRAPHY;

AGED; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY OCCLUSION; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELLS;

EID: 39749196134     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0284     Document Type: Article

References (31)

1. Matsunaga T, Warltier DC, Weihrauch DW, Moniz M, Tessmer J, Chilian WM. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 102: 3098-3103, 2000.
2. Murohara. T, Asahara T, Silver M, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101: 2567-2578, 1998.
3. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600, 2003.
4. Kawamoto A, Tkebuchava T, Yamaguchi J, et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107: 461-468, 2003.
5. Conway EM, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res 49: 507-521, 2001.
6. Waltenberger J. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res 49: 554-560, 2001.
7. Fuchs S, Baffour R, Zhou YF, et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 37: 1726-1732, 2001.
8. Kamihata H, Matsubara. H, Nishiue T, et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104: 1046-1052, 2001.
9. Werner GS, Ferrari M, Heinke S, et al. Angiographic assessment of collateral connections in comparison with invasively determined collateral function in chronic coronary occlusions. Circulation 107 (15): 1972-1977, 2003.
10. Berman DS, Kiat H, Friedman JD, et al, Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardlol 22: 1455-1464, 1993.
11. Rentrop KP, Cohen M, Blanke H, et al. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 5: 587-592, 1985.
12. Werner GS, Ferrari M, Beige S, et al. Collateral function in chronic total coronary occlusions is related to regional myocardial function and duration of occlusion. Circulation 104 (23): 2784-2790, 2001.
13. Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 81: 491-497, 1990.
14. Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92: 9363-9367, 1995.
15. Matsuo Y, Imanishi T, Hayashi Y, et al. The effect of senescence of endothelial progenitor cells on in-stent restenosis in patients undergoing coronary stenting. Intern Med 45: 581-587, 2006.
16. Schaper W, Sharma HS, Quinkler W, et al. Molecular biologic concepts of coronary anastomoses. J Am Coll Cardiol 15: 513-518, 1990.
17. Sherman JA, Hall A, Malenka DJ, et al, Humoral and cellular factors responsible for coronary collateral formation. Am J Cardiol 98 (9): 1194-1197, 2006.
18. Briguori C, Testa U, Colombo A, et al. Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals. Am J Cardiol 97 (4): 472-476, 2006.
19. Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89: E1-7, 2001.
20. Assmus B, Urbich C, Aicher A, et al. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res 92: 1049-1055, 2003.
21. Imanishi T, Hano T, Sawamura T, et al. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol 31: 407-413, 2004.
22. Imanishi T, Hano T, Nishio I. Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J Hypertens 23: 97-104, 2005.
23. Ziegelhoeffer T, Fernandez B, Kostin S, et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 94: 230-238, 2005.
24. Koerselman J, van der Graaf Y, de Jaegere PP, et al. Coronary collaterals: an important and underexposed aspect of coronary artery disease. Circulation 107: 2507-2511, 2003.
25. Lambiase PD, Edwards RJ, Anthopoulos P, et al. Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support. Circulation 109: 2986-2992, 2004.
26. Fujita M, Ikemoto M, Kisbishita M, et al. Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation 94: 610-613, 1996.
27. Gibson CM, Ryan K, Sparano A, et al. Angiographic method to assess human coronary angiogenesis. Am Heart J 137: 169-179, 1999.
28. Tepper OM, Galiano, RD, Capla JM, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106: 2781-2786, 2002.
29. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 97: 3422-3427, 2000.
30. Rehman J, Li J, Orschell CM, et al. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107: 1164-1169, 2003.
31. Arras M, Ito WD, Scholz D, et al. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 101: 40-50, 1998.